Drugs and Devices

FDA approves Lucentis for diabetic macular edema

On Aug. 10, the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares